The cells that slough off from a cancerous tumor into the bloodstream are a genetically diverse bunch, Stanford University School of Medicine researchers have found.

Ability to culture rare tumor cells isolated from blood could help improve patient response to therapy

RARITAN, N.J., April 23, 2012 /PRNewswire/ -- Veridex, LLC announced today that it has joined with Novartis Pharmaceuticals Corporation in an educational alliance to encourage and facilitate

HOUSTON, April 2, 2012 /PRNewswire/ -- Scientists at ApoCell, Inc., in partnership with researchers at Virginia Commonwealth University (VCU) Massey Cancer Center, have used the company's

CHICAGO, April 2, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced results of three preclinical studies focused on c-MET, a receptor tyrosine kinase that, when it functions